Show Results For
- All HBS Web
(3,956)
- People (16)
- News (897)
- Research (2,231)
- Events (10)
- Multimedia (94)
- Faculty Publications (1,699)
Show Results For
- All HBS Web
(3,956)
- People (16)
- News (897)
- Research (2,231)
- Events (10)
- Multimedia (94)
- Faculty Publications (1,699)
- 09 Jul 2020
- Working Paper Summaries
How Should US Bank Regulators Respond to the COVID-19 Crisis?
- 22 Dec 2010
- News
Carlyle in talks to buy AlpInvest
Michael S. Kaufman
A Senior Lecturer at the Harvard Business School, Michael co-developed and teaches a second year MBA course, “Challenges and Opportunities in the Restaurant Industry.”
A founder and partner of Positive Strategy LLC, a management/strategy consulting... View Details
- September 2010
- Article
Do Inventory and Gross Margin Data Improve Sales Forecasts for U.S. Public Retailers?
- Research Summary
The Benefits of Selective Disclosure: Evidence from Private Firms
This paper explores an unexplored benefit of being privately-held: Non-SEC-filing private firms’ ability to disclose confidential information to selected investors minimizes the scope for information asymmetry between the firms and their investors. This decreases... View Details
- 12 Sep 2010
- News
To Create Jobs, Nurture Start-Ups
- September 2018 (Revised August 2021)
- Teaching Note
Blackstone at Age 30 and Blackstone at 35
- January 1999 (Revised April 2004)
- Case
Infox System GmbH
Robert S. Huckman
Robert Huckman is the Albert J. Weatherhead III Professor of Business Administration at Harvard Business School, the Howard Cox Faculty Chair of the HBS Healthcare Initiative, and the Senior Associate Dean for External... View Details
- September 1986 (Revised July 2001)
- Case
Eastern Electric Apparatus Repair Company (A)
- 18 May 2015
- News
Harvard Business School Launches Gender Initiative
- 22 Feb 2013
- News
Mindful of Bubbles in a Boom for Deals
- 11 Mar 2018
- News
SoftBank Looks to Invade Wall Street’s Turf
- 13 May 2019
- HBS Seminar
Christian Catalini, MIT Sloan School of Management
- October 1986 (Revised February 2008)
- Case
Congoleum Corp. (Abridged)
- February 2016 (Revised February 2017)
- Case
Alvogen
Robert Wessman, Alvogen’s CEO, was also previously the CEO of Actavis, another Icelandic generics... View Details
- January 1989 (Revised October 1993)
- Background Note
Note: Valuing a Business Acquisition Opportunity
- January 2007 (Revised May 2008)
- Case